Dec 20, 2022
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced the closing of its underwritten public offering with gross proceeds to the company to be $8,000,000. The offering consists of 1,600,000 units and pre-funded units, with each unit consisting of one American Depositary Share (“ADS”) and two warrants, each to purchase one ADS. Each pre-funded unit consists of one pre-funded warrant to purchase one ADS and two warrants each to purchase one ADS. BiondVax expects to use the net proceeds, together with its existing cash and cash equivalents, for the advancement of its NanoAbs development program and general corporate purposes, which may include working capital, research and development activities, regulatory matters, capital investment or other related purposes. Aegis Capital Corp. acted as the sole book-running manager for the offering.
To view the full press release, visit https://ibn.fm/ovOSe
About BiondVax Pharmaceuticals Ltd.
BiondVax is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, BiondVax has executed eight clinical trials including a seven-country, 12,400-participant phase 3 trial of its prior vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (“NanoAb”) pipeline. For more information, visit the company’s website at www.BiondVax.com.
NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
Milan, Italy’s fashion capital and home to this year’s World’s 50 Best Bars awards ceremony, offers bites as exquisite as its reputation. For those checking out the awards this month, be sure to make time for the city’s food scene, which is every bit as compelling as its bar culture. Alongside traditional trattorias, a new generation of chefs with fine-dining pedigrees steps away from rigid traditions, experimenting with fermentation menus, sustainable work hours, and a fusion of cultures....
As international fashion companies increasingly incorporate traditional Chinese design elements into their collections, accusations of cultural appropriation have flooded social media. In recent years, brands such as Zara and Adidas have been criticised for adopting Chinese tailoring features such as Mandarin collars and pankou, or frog buttons. While Zara drew backlash for mislabelling these elements as generic “fireman clasps” without acknowledging their heritage, Adidas sparked debate over...
Thanks for these recs, jet-setters. View Entire Post ›
Munich’s Oktoberfest was never on my travel bucket list. But it offered a chance to meet up with good friends from Hong Kong and their adorable toddler, Joshua, who go to the festival every year as a family. So there I was, spending a weekend at Theresienwiese, surrounded by bewildering varieties of beer and their drinkers. The annual Oktoberfest, first held in October 1810 to celebrate a royal wedding, is about more than just beer. There are amusement rides, games, stalls selling things you...
These latest launches offer something for every taste, from reimagined icons and richly textured wardrobe staples to playful collaborations and unexpected home accessories. Whether you are looking for an elegant pair of slingbacks, embellished sneakers, a statement basketball hoop or vibrant glass tableware, there is plenty to discover. Fendi For her first Fendi collection – fall/winter 2026 – chief creative officer Maria Grazia Chiuri revisited one of the label’s signature shoes, the Colibrì...
Ever heard of lipoprotein(a)? Don’t worry if you have not. That is the name of a cardiovascular risk factor that many people are genuinely unaware of. Two experts explain why it makes sense to have this value measured with a blood test at least once, and what to do if the result turns out to be too high. What exactly is lipoprotein(a)? Lipoprotein(a), or Lp(a), is a component of the blood. “It is structured like ‘bad’ LDL cholesterol,” says Anja Vogt, a specialist in internal medicine and deputy...
“My friends are very respectful of my situation… There's no expectation of, like, taking care of something or, you know, just having me be responsible for them.“ View Entire Post ›
Lisa Driscoll didn't show up to court on Thursday for what was supposed to be her long-awaited sentencing hearing. Lucky for her, the judge wasn't there either.
Lead cast: Kim Ji-yeon (aka Bona), Park Seo-ham, Jang Se-hyuk Latest Nielsen rating: 0.5 per cent In the new fantasy romance Dive into You, a mysterious camcorder allows a pair of superstar siblings to travel back in time and swap bodies in a desperate bid to save a loved one. Kim Ji-yeon (Twenty-Five Twenty-One) – also known as Bona from the K-pop girl group WJSN – appears as screen siren Yoon Ha-na, who has reached the top of her field but is experiencing an emotional numbness that affects her...
Popcorn, a movie and some final kisses at the Grove. It was a breakup date I'd never forget. But are we really over?
London Fashion Week drew the clothing crowd from New York to the British capital to see the highly anticipated return of Alexander McQueen and the debut of Christopher Kane at Mulberry. The event, which ran from September 17 to 21, showcased memorable collections from Erdem, Roksanda, Simone Rocha and Pauline Dujancourt. The week was rounded off by Burberry designer Daniel Lee’s collaboration with textile designer Celia Birtwell. London Fashion Week has since also become a platform for the...
The region of Calvià, Mallorca, has been shortlisted as a finalist for the European Capital of Tourism 2027, joining a select group of destinations recognised by the European Commission for their leadership in smart and sustainable tourism. Calvià is one of eight finalists in the category for cities of 25,000-100,000 inhabitants, selected from across 17 countries.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.